Finzati - Logo
PASW logo

Ping An Biomedical Co., Ltd.

PASW • Industrial - Distribution
$0.00
— 0.00 (0.00%)
EarningsLatest report: Sep 30, 2024
WEAK PROFILEWeakConfidence: 62%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$2.98M
Growth
-100.0%
Cash Flow
1/5
Trend
Volatile
Evidence
Weak liquidity · 0.84Negative growth trendWeak profitability
Financial data as of: Sep 30, 2024, 12:00 AM UTCLast earnings update: Sep 30, 2024, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$2.98M
52W Range0.12 - 5.40
Beta2.74
Gross Margin6.18%
Oper. Margin-0.00%
Profit Margin-1.47%
Debt/Eq-1.50
Current Ratio0.84
Quick Ratio0.84
Revenue 5Y-100.00%

Investment DNA

How strong this company looks for long-term investors

31
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
31/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
39/100
Why this score▼
Weak liquidity · 0.84Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 7/18/2025
Industry: Industrial - Distribution
P/B i: 0.00
Debt / Equity i: -1.50
Operating Margin: -0.00%
Net Margin: -1.47%
ROE i: -
ROIC: -

Financial Health

Score6 / 20
Debt / Equity: -1.50
Current Ratio: 0.84
Quick Ratio: 0.84
Status: Weak

Warnings

  • Weak Liquidity

Insider Transactions

Recent executive and insider activity

Liu Pijun (PJL)
Transaction: 10/14/2025
OTHER
Change
0
Price
Not reported
Filing
04/08/2026
Type
OTHER
Yang Hongli (HLY)
Transaction: 10/14/2025
OTHER
Change
0
Price
Not reported
Filing
04/01/2026
Type
OTHER
Liu Xianzhi (XZL)
Transaction: 10/14/2025
OTHER
Change
0
Price
Not reported
Filing
04/01/2026
Type
OTHER